LEANNE AVERY: Open Payments
NPI 1487619680 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 17 payments from 10 companies in 2025. Trend: 2023 $144 · 2024 $1,547 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $189 |
| Galderma Laboratories, L.P. | 2 | $150 |
| GENZYME CORPORATION | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 1 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $48 |
| Janssen Biotech, Inc. | 2 | $42 |
| LEO Pharma Inc. | 1 | $37 |
| UCB, Inc. | 2 | $36 |
| Boston Scientific Corporation | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
Products named: SKYRIZI, NEMLUVIO, DUPIXENT, ILUMYA, TREMFYA, ADBRY, Bimzelx, RINVOQ.
Industry payments across NC — which companies pay providers there.
